#VolatilityWatch Solid Bioscences by follow_the_money on TradingView.com Biotech buyouts have been very strong, especially with Gene therapy stocks as of late. Bounced off Lower end of channel … [Read more...] about Solid’s Swing Potential
Bearish Butterfly by follow_the_money on TradingView.com Seattle Genetics (Nasdaq: SGEN) has beat biotech averages significantly the past few months and has come to meet my $80 pt which also … [Read more...] about Bearish Butterfly Setup
Product Surprises Street #VolatilityWatch by follow_the_money on TradingView.com Press play button on chart to expand and see live price action. What happened? TherapeuticsMD (Nasdaq: TXMD) … [Read more...] about TXMD: Product Surprises Street
Press play on chart to watch IMMU trade in real-time. #IMMU look at Risk vs. Reward #Volatilitywatch by follow_the_money on TradingView.com Immunomedics Inc. (Nasdaq: IMMU) brings … [Read more...] about Immunomedics’ Risk vs. Reward
Recent data release may have changed SGMO's future outlook. Sangamo's long-term chart suggests a potential pullback to $4 is a possibility, but that was before a recent data release by the company … [Read more...] about Sangamo Therapeutics Inc.(Nasdaq: SGMO) – Doom Or Gloom Scenario
ADMA #VolatilityWatch by follow_the_money on TradingView.com Supply and demand trade that will make money, even in a Bear market. ADMA Biologics (Nasdaq: ADMA) is a great defensive play, … [Read more...] about ADMA Supply & Demand
ZYNE #VolatilityWatch by follow_the_money on TradingView.com Zynerba Pharmaceuticals (NASDAQ: ZYNE) announced 5/29/2019, initiation of phase 2 INSIPRE trial for its lead product ZYGEL. ZYGEL is a … [Read more...] about ZYNE– Is this Canna-biz a buy now?